What does ipamorelin research measure?
The short answer
Answered from published research literature only. It describes what that literature examines; it is not a statement about use in people. Ipamorelin is investigational research material and is not an approved product.
Ipamorelin is described as one of the earliest selective growth-hormone secretagogues. The published work reports growth-hormone-axis endpoints in rat models — longitudinal bone growth, bone mineral content, and bone formation under glucocorticoid challenge.9849822103733431082884011735244
A separate strand examines pancreatic insulin release in rat preparations.15665799
Cited literature
- Ipamorelin, the first selective growth hormone secretagogueRaun K, et al. · European Journal of Endocrinology · 1998PMID 9849822 ↗
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsJohansen PB, et al. · Growth Hormone & IGF Research · 1999PMID 10373343 ↗
- The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female ratsSvensson J, et al. · The Journal of Endocrinology · 2000PMID 10828840 ↗
- The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult ratsAndersen NB, et al. · Growth Hormone & IGF Research · 2001PMID 11735244 ↗
- Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic ratsAdeghate E, et al. · Neuroendocrinology Letters · 2004PMID 15665799 ↗
Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.